"FDA Alert: Abiomed Heart Pump Recall Linked to 49 Deaths"
The FDA has issued an alert regarding the Impella heart pump, linking it to 49 deaths and numerous injuries, citing the risk of puncturing the heart's wall. Despite this, the device will remain in use. The manufacturer, Abiomed, was faulted for delayed notice of complications, and the FDA has received additional reports of heart-wall tears linked to patient deaths since the initial notice in 2021. This alert adds to concerns about the deadly side effects of cardiac devices, particularly those that take over the heart's blood-circulating function.